Health Issues in First Episode of Psychosis

<p>Do people with schizophrenia already have a high risk of metabolic effects early in the course of illness?</p> <p>This episode discusses health concerns for first-episode patients, including life expectancy, metabolic conditions in drug-naïve patients, the signs of developing insulin resistance, and the approaches for early metabolic changes. </p> <p>Faculty: Stephen Marder, M.D. <br /> Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.</p> <ul> <li><strong><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC156"> Learn more about our memberships here</a></strong></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/assessment-and-management-of-first-episode-of-psychosis-2611?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC156"> <strong>Earn 0.75 CMEs: Assessment and Management of First Episode of Psychosis</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/health-concerns-for-first-episode-patients-2611-5115?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC156"> <strong>Health Concerns for First-Episode Patients</strong></a></li> </ul> <p> </p>